findmyKOL

Edward Tuohy, MD

Basic profile

Yale New Haven Health System

ORCIDNone on fileNPI
RegionFairfield, CT · NortheastSpecialtyInterventional CardiologyFocusCardiology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Edward Tuohy is a Cardiology physician affiliated with Yale New Haven Health System. OpenAlex indexes 13 publications with 369 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
13publications

Distinct works indexed by OpenAlex.

369citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1305 Post Rd
Fairfield, CT 068246016

Telephone

203-292-2000

Registry record last updated 16 Jan 2015.

View the NPPES registry record

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    82.5%
    Statin21.1%
    Atorvastatin Calcium48%Rosuvastatin Calcium43%Pravastatin Sodium8%Simvastatin1%Fluvastatin Er1%
    Part D<11 patients
    Beta blocker16.6%
    Metoprolol Succinate62%Carvedilol15%Metoprolol Tartrate13%Atenolol4%Nebivolol Hcl2%Propranolol Hcl Er1%Sotalol1%Propranolol Hcl1%Carvedilol Er1%
    Part D<11 patients

    + 20 more classes in this area

  • Blood & clotting

    13.4%
    P2Y12 inhibitor7.5%
    Clopidogrel93%Prasugrel Hcl5%Brilinta2%
    Part D<11 patients
    Factor Xa inhibitor5.5%
    Eliquis63%Xarelto37%
    Part D109 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    2.8%
    SGLT2 inhibitor1.5%
    Farxiga61%Jardiance40%
    Part D33 patients
    Potassium supplement0.7%
    Potassium Chloride83%Klor-Con M2017%
    Part D<11 patients

    + 4 more classes in this area

Where care is delivered (Part B)35.6% facility · 64.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”